MAP2K7 and gastrointestinal stromal tumor: Although IM significantly inhibited KIT, AKT and MAPK phosphorylation in GIST882, it only partially suppressed the downstream MAPK signaling in GIST-T1 (50% inhibition) and complete inhibition required the addition of the MEK inhibitor PD (Fig 3, left panel).